Birmingham, West Midlands -- (SBWIRE) -- 12/05/2013 -- Value Penny Stocks issues special report on McDermott International (NYSE:MDR), New Residential Investment Corp (NYSE:NRZ), Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE), Novavax, Inc. (NASDAQ:NVAX).
McDermott International (NYSE:MDR) opened its last trade at the price of $7.78. Its closing price was $7.87 after gaining +1.03% for the day. The company traded with the total volume of 4,557,950 shares, while its average trading volume remained 5.54 million shares. The beta of this stock stands at 1.48. McDermott International, Inc. operates as an engineering, procurement, construction, and installation (EPCI) company worldwide. The company operates in three segments: Asia Pacific, Atlantic, and the Middle East.
For How Long MDR will Fight for Profitability? Read This Trend Analysis report
New Residential Investment Corp (NYSE:NRZ) percentage change surged 4.64% to close at $6.31 with the total traded volume of 4,492,053 shares, along with average volume of 2.60 million shares. The 52 week range of the stock remained $5.79 - $7.29, while its day lowest price was $5.96. The share price hit the day highest price of $6.35. New Residential Investment Corp., a real estate investment trust, focuses on investing in residential mortgage related assets. The company is involved in the direct and indirect investments in excess mortgage servicing rights; and in real estate securities and loans.
For How Long NRZ’s Gloss will Attract Investors? Find out via this report
Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) traded on volume of 4,358,596 shares in the last session against average volume of 7.41 million shares. The company started its trading session with the price of $5.14 and closed at $5.34 by scoring +2.69%. Yingli Green Energy Holding Company Limited, together with its subsidiaries, engages in the design, development, manufacture, assembly, sale, and installation of photovoltaic (PV) products and related accessories worldwide.
Will YGE Continue To Move Higher? Find Out Here
Novavax, Inc. (NASDAQ:NVAX) started its last trading session with the price of $3.96 and closed at $4.01 by scoring +0.75%. The stock traded with total volume of 4,307,687 shares, while the average trading volume remained 3.62 million shares. The beta value of this stock stands at 2.41. Day range for the stock was $3.81 - $4.08. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. The company’s technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles (VLPs) and recombinant protein micelle vaccines.
Why Should Investors Buy NVAX After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)